Drawing on my clinical practice, as an early career researcher, I study safe and effective use of medicines.

Since the beginning of the pandemic, I have been interested in how it has impacted NHS patients. I have been studying pharmacoepidemiology through prescription reimbursement data to examine the variations in medicines use across England, by indication, and cost. My pandemic related research finds many differences in how medicines are used across England. Lower prescriptions after March 2020, suggest that people (who are elderly, have multiple diseases, take many medicines and those with complex issues) do not have access to their routine medicines (eg for renal transplant, prostate cancer, and respiratory patients) with downward trends. This might signal poor drug adherence, disease escalation, increasing disability and earlier death for some people, which urgently needs to be studied and 'just in time' solutions are needed. Eectronic health data can be evaluated to provide early strategies to combat this.

To help me get better at modelling, I have attended training at University of Oxford (Big Data Epidemiology, Essential Medical Statistics, Statistical Computing with R and Stata)

My other pharmacy practice research is in the areas of Falsified Medicines, community pharmacy services, electronic cigarettes (e-cigarettes) and misuse and abuse of over-the-counter medicines eg codeine/co-codamol. I use a variety of data sources (e.g. cross-sectional or epidemiological databases) to describe current practice (e.g. through text, maps, statistics and discourse) to consider ways in which patient care and safety could be improved.

As my research capacity and expertise continues to grow, I am increasingly analysing data from UK electronic medical health records to provide a national narrative on the medicines supplied by pharmacies. The pandemic has driven my curiosity in understanding how prescription medicines are used across the nation, and more importantly, to identify gaps and health inequalities, by region. I am increasingly interested in prescription medicine price analysis and the availability of stock, especially in light of the serious shortage protocol and related legislations that came in force in June/July 2019.

I supervise students across a range of pharmacy practice research interests, including MPharm, MRes, MSc and PhD.

I graduated with an MPharm (Hons) Pharmacy degree from the University of Portsmouth and completed my pre-registration at Southampton General Hospital, University Hospital Southampton NHS Foundation Trust (UHS). I completed MSc Finance at Grenoble Graduate School of Business within Grenoble Ecole de Management. After seven years of community pharmacy practice, I returned to secondary care as a Clinical Trial’s Pharmacist. I have been an academic part-time since 2010-11 and full-time since 2014-15. I have taught in the School of Pharmacy at the University of Portsmouth, University College London and University of Brighton and have been teaching at the Brighton and Sussex Medical School since 2018-19.

I have invested time in developing my educational record, which include the following formal courses in addition to my undergraduate and postgraduate qualifications, aside from the self-directed study in scholarship and continued professional development as part of my professional body registration requirements:
a) Big Data Epidemiology (11 - 15 January 2021);
b) Essential Medical Statistics (8 March to 7 May 2021);
c) Statistical Computing with R and Stata (26 April to 18 June 2021) - all short-course at the University of Oxford for academic credit (20 credits each) 2020-21.

The London School of Economics and Political Science: Modelling Cost-Effectiveness in Healthcare (11 May to 5 July 2022).

In my ‘outside the university’ role as a NHS research ethics expert committee member (for the last five years), I have reviewed UK-wide trials and provided my committee with technical advice to make a final judgement on the ethical approval of running the studies in the UK and what this means for the rights, safety, dignity and confidentiality of participants. I was the lead reviewer in the UK for the ramdesivier trial which is the only drug that has been licensed for use in the COVID-19 pandemic globally. I have been a NHS Research Ethics Committee Member since Nov 2015 and have personally reviewed over 50+ studies (40+ being Clinical Trials of an Investigational Medicinal Product (CTIMP) or device) as the lead or second reviewer, within the 200+ studies reviewed by the whole committee. In 2021, I have been appointed as the Alternate Vice Chair of my committee for a period of three years.

I'm open to knowledge exchange with public and private companies and other related activities.

Much of my teaching is in Pharmacy Practice, on The Masters of Pharmacy (MPharm) degree programme, Overseas (non-EEA) Pharmacists Assessment Programme (OSPAP) as well as MSc Pharmacy courses. I also teach on the Bachelor of Medicine, Bachelor of Surgery (MBBS) course within Brighton and Sussex Medical School (BSMS).

I have taken and passed the UK registration exams (2005) and the Competency Assessment of Overseas Pharmacist (CAOP, Stream B) exam set by the Australian Pharmacy Council (2012). This personal experience helps me completely understand the student perspective and the student journey through the university's life course with respect to Pharmacy.

I try to teach in ways that promotes active connections between the fundamental sciences and impact on patient care. I use technology in my teaching to aid blended learning, real-time capture and interactive teaching.